|Articles|October 18, 2021
Benefits of Biocatalysis with the Right API CDMO v2
Author(s)Wavelength Pharmaceuticals
Learn how enzymatic chemistry increases conversion efficiency for higher yields with fewer by-products, and what to look for in an API CDMO partner for biocatalysis.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
4
Navigating Financial and Opportunity Risks in Accelerated Drug Launches
5